🔴 HCW Biologics is trading 6.2% down in after-hours trading with no clear company-specific catalyst

HCW Biologics is trading at $1.10, down 6.19% in after-hours trading, with no clear company-specific announcement explaining the decline.

• The latest company release found was October 9 and covered progress toward an IND filing targeted for the first half of 2027.
• The S&P 500 and Dow were down while the Nasdaq rose, offering no clear broad-market explanation for the move.
• No reliable trading-volume details were available.